The Biotech Growth Trust PLC (BIOGL.XC)
Cboe UK · GBp · Financial Services · Asset Management
£1,334.00 (+0.00%) as of
Key statistics
- Market cap
- 265.86M
- P/E (TTM)
- 4.98
- EPS (TTM)
- 2.68
- 52-week range
- 893.00 – 1,334.00
- Beta
- 0.32
- Revenue (TTM)
- 135.02M
- Profit margin
- 96.47%
- Volume
- 557.00
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
- Sector
- Financial Services
- Industry
- Asset Management
- Headquarters
- New York, NY, United States
biotechgt.com/index.php/biog/home/overview/
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- GREAT SOUTHERN COPPER PLC ORD G (GSCU.L)
- NCC AB NCC B ORD SHS (0OFP.IL)
- DAIMLER TRUCK HOLDING AG DAIMLE (0AB9.L)
- ELEKTA AB (PUBL) ELEKTA B ORD S (0O5H.IL)
- FRESENIUS SE & CO KGAA FRESENIU (0OO9.IL)
- PALO ALTO NETWORKS INC PALO ALT (0KF5.L)
- L E LUNDBERGFORETAGEN AB (PUBL) (0GWB.IL)
- SIEMENS HEALTHINEERS AG SIEMENS (0PMJ.L)